Open main menu
Home
Random
Recent changes
Special pages
Community portal
Preferences
About Wikipedia
Disclaimers
Incubator escapee wiki
Search
User menu
Talk
Dark mode
Contributions
Create account
Log in
Editing
Complement system
(section)
Warning:
You are not logged in. Your IP address will be publicly visible if you make any edits. If you
log in
or
create an account
, your edits will be attributed to your username, along with other benefits.
Anti-spam check. Do
not
fill this in!
=== Lectin pathway === {{Main|Lectin pathway}} The [[lectin]] pathway is homologous to the classical pathway, but with the opsonin, [[mannose-binding lectin]] (MBL), and [[ficolin]]s, instead of C1q. This pathway is activated by binding of MBL to mannose residues on the pathogen surface, which activates the MBL-associated serine proteases, [[MASP1 (protein)|MASP-1]], and [[MASP2 (protein)|MASP-2]] (very similar to [[Complement component 1r|C1r]] and [[C1s]], respectively), which can then split C4 into [[C4a]] and [[C4b]] and C2 into [[C2a]] and [[C2b]]. C4b and C2b then bind together to form the classical [[C3-convertase]], as in the classical pathway. Ficolins are homologous to MBL and function via MASP in a similar way. Several [[single-nucleotide polymorphism]]s have been described in M-ficolin in humans, with effect on ligand-binding ability and serum levels. Historically, the larger fragment of C2 was named C2a, but it is now referred to as C2b.<ref>{{Cite journal |display-authors=6 |vauthors=Ammitzbøll CG, Kjær TR, Steffensen R, Stengaard-Pedersen K, Nielsen HJ, Thiel S, Bøgsted M, Jensenius JC |year=2012 |title=Non-synonymous polymorphisms in the FCN1 gene determine ligand-binding ability and serum levels of M-ficolin |journal=PLOS ONE |volume=7 |issue=11 |pages=e50585 |bibcode=2012PLoSO...750585A |doi=10.1371/journal.pone.0050585 |pmc=3509001 |pmid=23209787 |doi-access=free}}</ref> In invertebrates without an adaptive immune system, ficolins are expanded and their binding specificities diversified to compensate for the lack of pathogen-specific recognition molecules.{{citation needed|date=July 2022}}
Edit summary
(Briefly describe your changes)
By publishing changes, you agree to the
Terms of Use
, and you irrevocably agree to release your contribution under the
CC BY-SA 4.0 License
and the
GFDL
. You agree that a hyperlink or URL is sufficient attribution under the Creative Commons license.
Cancel
Editing help
(opens in new window)